Arteriosclerosis Thrombosis and Vascular Biology · 2003 · 54 citations · 26 references
NursingPharmacologyAgingApoptosisGeriatric PharmacologyAge-related Physiologic ChangesAging PhysiologyAge-related Cardiovascular ChangesCellular ProliferationMek InhibitorsMitogen-activated Protein Kinase CascadesMitogen-activated Protein Kinase KinaseMitogen-activated Protein Kinase PathwaysProliferative IndexVascular Smooth Muscle Cell Proliferation
OBJECTIVE: Age-dependent increase in vascular smooth muscle cell (VSMC) proliferation is thought to contribute to the pathology of atherosclerotic diseases. In this study, we investigated the role of mitogen-activated protein kinases (MAPKs) on VSMC proliferation and neointimal formation in the context of aging. METHODS AND RESULTS: VSMCs were isolated from the aorta of young and old rabbits. The proliferative index after serum stimulation was significantly increased in old versus young VSMCs. This was associated with a significant and specific age-dependent increase in p44/p42 MAPK activation. Treatment with MEK inhibitor PD98059 successfully inhibited p44/p42 MAPK activities and VSMC proliferation. These results were confirmed in vivo using a model of balloon injury in rabbit iliac arteries. p44/p42 MAPK activities were rapidly induced by angioplasty in young and old animals. However, the levels of p44/p42 MAPK activities achieved in arteries of old rabbits were significantly higher than those of young rabbits. This was associated with a higher cellular proliferative index and a significant increase in neointimal formation in old animals. Local delivery of PD98059 in old rabbits successfully inhibited p44/p42 MAPK activities after angioplasty, which led to a significant reduction in cellular proliferation and neointimal formation in treated animals. CONCLUSIONS: Our study suggests for the first time that increased p44/p42 MAPK activation contributes to augmented VSMC proliferation and neointimal formation with aging. p44/p42 MAPK inhibition could represent a novel therapeutic avenue against atherosclerotic diseases.
26
Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis
Zhengui Xia, Martin Dickens, Joël Raingeaud et al. · Science · 1995 · 5.3K citations
Ken’ichiro Hayashi, Masanori Takahashi, Kazuhiro Kimura et al. · The Journal of Cell Biology · 1999 · 190 citations · Full text
Yanhua Hu, Linda Cheng, Boris-Wolfgang Hochleitner et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1997 · 172 citations · Full text